Bjelland I, Dahl AA, Haug TT, Neckelmann D The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res. 2002 Feb;52(2):69-77. Review.
Boyes A, D'Este C, Carey M, Lecathelinais C, Girgis A How does the Distress Thermometer compare to the Hospital Anxiety and Depression Scale for detecting possible cases of psychological morbidity among cancer survivors? Support Care Cancer. 2013 Jan;21(1):119-27. doi: 10.1007/s00520-012-1499-3. Epub 2012 May 24.
Burris JL, Andrykowski M Disparities in mental health between rural and nonrural cancer survivors: a preliminary study. Psychooncology. 2010 Jun;19(6):637-45. doi: 10.1002/pon.1600.
Coups EJ, Ostroff JS A population-based estimate of the prevalence of behavioral risk factors among adult cancer survivors and noncancer controls. Prev Med. 2005 Jun;40(6):702-11.
Donovan KA, Grassi L, McGinty HL, Jacobsen PB Validation of the distress thermometer worldwide: state of the science. Psychooncology. 2014 Mar;23(3):241-50. doi: 10.1002/pon.3430. Epub 2013 Nov 11. Review.
Dudgeon DJ, Lertzman M, Askew GR Physiological changes and clinical correlations of dyspnea in cancer outpatients. J Pain Symptom Manage. 2001 May;21(5):373-9.
Dudgeon DJ, Lertzman M Dyspnea in the advanced cancer patient. J Pain Symptom Manage. 1998 Oct;16(4):212-9.
Dyspnea Mechanisms, assessment, and management: a consensus statement. American Thoracic Society. Am J Respir Crit Care Med. 1999 Jan;159(1):321-40. Review.
Eisen AR, Rapee RM, Barlow DH The effects of breathing rate and pCO2 levels on relaxation and anxiety in a non-clinical population. Journal of Anxiety Disorders 1990;4(3):183-90
Ekman I, Kjellström B, Falk K, Norman J, Swedberg K Impact of device-guided slow breathing on symptoms of chronic heart failure: a randomized, controlled feasibility study. Eur J Heart Fail. 2011 Sep;13(9):1000-5. doi: 10.1093/eurjhf/hfr090. Epub 2011 Jul 28.
El-Sayed AM, Haloossim MR, Galea S, Koenen KC Epigenetic modifications associated with suicide and common mood and anxiety disorders: a systematic review of the literature. Biol Mood Anxiety Disord. 2012 Jun 14;2:10. doi: 10.1186/2045-5380-2-10.
Gallo-Silver L, Pollack B Behavioral interventions for lung cancer-related breathlessness. Cancer Pract. 2000 Nov-Dec;8(6):268-73. Review.
Garcia SF, George J, Rosenbloom SK, Cella D Adapting chronic illness health related quality of life item banks for cancer populations. In Poster presented at the International Society for Quality of LifeResearch on Patient-Reported Outcomes in Clinical Practice, Budapest, Hungary. In 2007.
Gift AG Validation of a vertical visual analogue scale as a measure of clinical dyspnea. Rehabil Nurs. 1989 Nov-Dec;14(6):323-5.
Gupta D, Lis CG, Grutsch JF The relationship between dyspnea and patient satisfaction with quality of life in advanced cancer. Support Care Cancer. 2007 May;15(5):533-8. Epub 2006 Nov 21.
Hazlett-Stevens H, Craske MG BREATHING RETRAINING AND DIAPHRAGMATIC BREATHING. In General principles and empirically supported techniques of cognitive behavior therapy. 2009.
Henoch I, Bergman B, Danielson E Dyspnea experience and management strategies in patients with lung cancer. Psychooncology. 2008 Jul;17(7):709-15.
Hopwood P, Stephens RJ Symptoms at presentation for treatment in patients with lung cancer: implications for the evaluation of palliative treatment. The Medical Research Council (MRC) Lung Cancer Working Party. Br J Cancer. 1995 Mar;71(3):633-6.
Jacobsen PB DKSZetal Management of anxiety and depression in adult cancer patients: Toward an evidence-based approach. In: Chang AE GPHDea, editor. Oncology: An Evidence-Based Approach. Philadelphia, PA: Springer; 2006. p. 1552-79.
Jacobsen PB, Jim HS Psychosocial interventions for anxiety and depression in adult cancer patients: achievements and challenges. CA Cancer J Clin. 2008 Jul-Aug;58(4):214-30. doi: 10.3322/CA.2008.0003. Epub 2008 Jun 16. Review.
Jerath R, Edry JW, Barnes VA, Jerath V Physiology of long pranayamic breathing: neural respiratory elements may provide a mechanism that explains how slow deep breathing shifts the autonomic nervous system. Med Hypotheses. 2006;67(3):566-71. Epub 2006 Apr 18.
Linden W, Vodermaier A, Mackenzie R, Greig D Anxiety and depression after cancer diagnosis: prevalence rates by cancer type, gender, and age. J Affect Disord. 2012 Dec 10;141(2-3):343-51. doi: 10.1016/j.jad.2012.03.025. Epub 2012 Jun 21.
Luckett T, Butow PN, King MT, Oguchi M, Heading G, Hackl NA, Rankin N, Price MA A review and recommendations for optimal outcome measures of anxiety, depression and general distress in studies evaluating psychosocial interventions for English-speaking adults with heterogeneous cancer diagnoses. Support Care Cancer. 2010 Oct;18(10):1241-62. doi: 10.1007/s00520-010-0932-8. Epub 2010 Jul 2. Review.
Muers MF, Round CE Palliation of symptoms in non-small cell lung cancer: a study by the Yorkshire Regional Cancer Organisation Thoracic Group. Thorax. 1993 Apr;48(4):339-43.
Pal GK, Velkumary S, Madanmohan Effect of short-term practice of breathing exercises on autonomic functions in normal human volunteers. Indian J Med Res. 2004 Aug;120(2):115-21.
Quist M, Langer SW, Rørth M, Christensen KB, Adamsen L "EXHALE": exercise as a strategy for rehabilitation in advanced stage lung cancer patients: a randomized clinical trial comparing the effects of 12 weeks supervised exercise intervention versus usual care for advanced stage lung cancer patients. BMC Cancer. 2013 Oct 14;13:477. doi: 10.1186/1471-2407-13-477.
Reiner R Integrating a portable biofeedback device into clinical practice for patients with anxiety disorders: results of a pilot study. Appl Psychophysiol Biofeedback. 2008 Mar;33(1):55-61. doi: 10.1007/s10484-007-9046-6. Epub 2008 Feb 20.
Reuben DB, Mor V Dyspnea in terminally ill cancer patients. Chest. 1986 Feb;89(2):234-6.
Ryan LS Psychosocial issues and lung cancer: a behavioral approach. Semin Oncol Nurs. 1996 Nov;12(4):318-23. Review.
Stamm BH, Piland NF, Lambert D, Speck NC A Rural Perspective on Health Care for the Whole Person. Professional Psychology: Research and Practice 2007;38(3):298-304
Stoppelbein L, Greening L A longitudinal study of the role of cortisol in posttraumatic stress disorder symptom clusters. Anxiety Stress Coping. 2015;28(1):17-30. doi: 10.1080/10615806.2014.923844. Epub 2014 Jun 17.
Tanaka K, Akechi T, Okuyama T, Nishiwaki Y, Uchitomi Y Prevalence and screening of dyspnea interfering with daily life activities in ambulatory patients with advanced lung cancer. J Pain Symptom Manage. 2002 Jun;23(6):484-9.
Uddin M, Koenen KC, Aiello AE, Wildman DE, de los Santos R, Galea S Epigenetic and inflammatory marker profiles associated with depression in a community-based epidemiologic sample. Psychol Med. 2011 May;41(5):997-1007. doi: 10.1017/S0033291710001674. Epub 2010 Sep 14.
Zhao I, Yates P Non-pharmacological interventions for breathlessness management in patients with lung cancer: a systematic review. Palliat Med. 2008 Sep;22(6):693-701. doi: 10.1177/0269216308095024. Review.
Zigmond AS, Snaith RP The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983 Jun;67(6):361-70.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.